XBI ETF holdings (NYSE) - Page 2 | MetaTrader

Tam grafiği aç Full chart

Genel Bakış Tüm yatırımlar Isı Haritası

En büyük yatırımlar Market Value Shares Weight %

ABBV AbbVie Inc 98.3 M 430.4 K 1.3%

GILD Gilead Sciences Inc 98.0 M 798.7 K 1.2%

Avidity Biosciences Inc 98.0 M 1.4 M 1.2%

IONS Ionis Pharmaceuticals Inc 97.5 M 1.2 M 1.2%

Cidara Therapeutics Inc 97.5 M 441.3 K 1.2%

UTHR United Therapeutics Corp 97.4 M 199.9 K 1.2%

Exact Sciences Corp 97.2 M 957.0 K 1.2%

BIIB Biogen Inc 96.0 M 545.8 K 1.2%

MIRM Mirum Pharmaceuticals Inc 96.0 M 1.2 M 1.2%

ALNY Alnylam Pharmaceuticals Inc 95.3 M 239.6 K 1.2%

NTRA Natera Inc 95.2 M 415.7 K 1.2%

CELC Celcuity Inc 94.9 M 951.6 K 1.2%

SRRK Scholar Rock Holding Corp 94.8 M 2.2 M 1.2%

ALKS Alkermes PLC 94.7 M 3.4 M 1.2%

TGTX TG Therapeutics Inc 94.4 M 3.2 M 1.2%

ARWR Arrowhead Pharmaceuticals Inc 93.4 M 1.4 M 1.2%

PTGX Protagonist Therapeutics Inc 92.6 M 1.1 M 1.2%

VKTX Viking Therapeutics Inc 90.8 M 2.6 M 1.2%

INSM Insmed Inc 88.8 M 510.4 K 1.1%

ADMA ADMA Biologics Inc 88.5 M 4.9 M 1.1%

1
2
3
4
5
6
7
8

Haberler

First Quarter Earnings: Sharpening Sector Divergence

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

3 Reasons To Stick With Growth Stocks In Rotating Markets

Seeking Innovation Beyond Tech? Insight On Healthcare Stocks

Biotech Investors Are Tuning Out the MAHA Chaos

Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)

Capricor hisse hedef fiyatı FDA ilerlemesi sonrası 63 dolar tutuldu

FDA Commissioner Marty Makary Expected To Resign, Ending Turbulent Stint

Why I Now Favor A Barbell Model Over Ray Dalio’s All-Weather Portfolio (SPY)

Biyoteknoloji hisseleri arasında açığa satışta en fazla artış Intellia’da - Baird

Mizuho, Immunocore için hedef fiyatı 34 dolara indirdi